Spliceosome protein EFTUD2: A potential pathogenetic factor in tumorigenesis and some developmental defects (Review)
Molecular Medicine Reports · 19.03.2025 · 31 (5) · 1-17
DOI: 10.3892/mmr.2025.13499 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Medicine Reports, online erschienen am 19.03.2025. Verfasst von Ankang Yin und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China. Hauptthemen laut MEDLINE: Spliceosomes, Carcinogenesis, Ribonucleoprotein, U5 Small Nuclear, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The formation of mature mRNA is inseparable from the processing of RNA precursors and splicing by the spliceosome. The spliceosome is a multi‑protein complex composed of five small nuclear ribonucleoproteins. Elongation factor Tu GTP binding domain containing 2 (EFTUD2) is a component of spliceosome complex that is involved in the reorganization of the spliceosome complex, thereby promoting the removal of introns from precursor mRNA. Therefore, EFTUD2 can regulate embryonic development and innate immunity by modulating the splicing of various mRNAs. The mutations in EFTUD2 itself also lead to developmental defects and clinical manifestations in mandibulofacial dysostosis, the nervous system, the circulatory system, the digestive system and the reproductive system. Furthermore, the overexpression of EFTUD2 promotes the progression of hepatocellular carcinoma, breast cancer and colorectal cancer. The present review discussed the molecular mechanisms by which EFTUD2 exerts its physiological functions, focusing on EFTUD2 mutations and their corresponding clinical manifestations. It aimed to provide insight for the diagnosis and treatment of EFTUD2‑related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China.
- Department of Clinical Laboratory, Tongde Hospital Affiliated to Zhejiang Chinese Medical University (Tongde Hospital of Zhejiang Province), Hangzhou, Zhejiang 310012, P.R. China.
Zitieren
APA
Yin, A., Zhu, Q., Chen, Y., & Wang, J. (2025). Spliceosome protein EFTUD2: A potential pathogenetic factor in tumorigenesis and some developmental defects (Review). Molecular Medicine Reports, 31(5), 1-17. https://doi.org/10.3892/mmr.2025.13499
Vancouver
Yin A, Zhu Q, Chen Y, Wang J. Spliceosome protein EFTUD2: A potential pathogenetic factor in tumorigenesis and some developmental defects (Review). Molecular Medicine Reports. 2025;31(5):1-17. doi:10.3892/mmr.2025.13499
BibTeX
@article{Yin2025,
author = {Yin, Ankang and Zhu, Qiuyu and Chen, Yi and Wang, Juan},
title = {Spliceosome protein EFTUD2: A potential pathogenetic factor in tumorigenesis and some developmental defects (Review)},
journal = {Molecular Medicine Reports},
year = {2025},
volume = {31},
number = {5},
pages = {1--17},
doi = {10.3892/mmr.2025.13499}
}
EUVIMED